Summary of clinical results
DUCRAY

Tolerance and efficacy of DEXYANE anti-scratching emollient cream
Tolerance and efficacy of DEXYANE anti-scratching emollient cream in patients with mild to moderate atopic eczema, under dermatological and pediatric control
Population
555 subjects (22 adults, 17 children, 16 infants) with mild to moderate atopic eczema (SCORAD between 10 and 25)
Application of DEXYANE anti-scratching emollient
Application once a day for 3 weeks, to the face and body
Usual cleansing product
Evaluation criteria
- Evolution of the severity of atopic eczema via the SCORAD questionnaire (Scoring atopic dermatitis)
- Scoring of the intensity of xerosis (4-point scale; 0 = absent to 4 very severe) and pruritus (VAS)
- Evaluation of the intensity of pruritus and its impact on quality of life (patient questionnaire)
- Skin tolerance under dermatological and pediatric control
Results
- Significant decrease in SCORAD of –58% after 1 week of application and –69% after 3 weeks (p<0.05)

- Significant decrease in pruritus intensity of -92% after 3 weeks of application

- Significant decrease in the intensity of xerosis of -43% after 3 weeks of application.
- Decrease in the intensity of pruritus and its impact on the quality of daily life perceived by the subjects after 3 weeks of application
- Very good skin tolerance
Conclusion
- Soothing effect on the clinical signs of atopic eczema
- Very good skin tolerance
More summaries of clinical results
Want to read on?
This access is reserved for professionals, registered on Pierre Fabre For Med.
To access the full content, please register or log in if you already have an account.